Bristol-Myers Squibb's flurry of dealmaking has continued with en expansion of its partnership with BridgeBio on drugs targeting SHP2, in the hope of combining them with its cancer immunotherapy ...
Bristol-Myers Squibb's deucravacitinib – one of the main pipeline assets in its $74 billion takeover of Celgene in 2019 – has been approved in its first market as a treatment for moderate-to-severe ...
The phase 3 comeback story Bristol Myers Squibb investors were eagerly anticipating is not to be—at least not this year. The highly anticipated Adept-2 study will not read out by year-end as ...
Many designs involve multiple engineering domains. For example, hybrid vehicles balance engine performance with emissions limits; UAVs balance thermal limitations on their batteries with ...
Explore the U.S. bicameral legislature, its structure with the House of Representatives and Senate, and the historical ...
Adam Hayes, Ph.D., CFA, is a financial writer with 15+ years Wall Street experience as a derivatives trader. Besides his extensive derivative trading expertise, Adam is an expert in economics and ...
The heart is a pump, and the blood goes round, and round, and round all the time. And why does it do that? Why can't it just have a rest? Well, the blood has to be kept moving around all the time ...
The visual system is the part of the central nervous system that is required for visual perception – receiving, processing and interpreting visual information to build a representation of the visual ...